Granulocyte-colony stimulating factor (G-CSF) plus cyclophosphamide at high dose is not warranted for peripheral blood stem cell mobilisation after bortezomib-based induction in transplant-eligible patients with multiple myeloma, an Australian study shows. A review of outcomes in 288 patients across six centres in Victoria found a non-significant difference in stem cell yield between patients receiving G-CSF ...
High dose cyclo ruled out in PBSC mobilisation
By Mardi Chapman
21 Mar 2018